home / stock / tern / tern quote
Last: | $8.20 |
---|---|
Change Percent: | -0.38% |
Open: | $8.01 |
Close: | $8.20 |
High: | $8.41 |
Low: | $7.98 |
Volume: | 1,746,341 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.2 | $8.01 | $8.2 | $8.41 | $7.98 | 1,746,341 | 06-14-2024 |
$7.98 | $7.44 | $7.98 | $8.415 | $7.36 | 2,645,385 | 06-13-2024 |
$7.39 | $7.53 | $7.39 | $7.6 | $7.2 | 1,175,557 | 06-12-2024 |
$7.33 | $6.91 | $7.33 | $7.48 | $6.79 | 913,640 | 06-11-2024 |
$6.99 | $7.17 | $6.99 | $7.17 | $6.85 | 911,833 | 06-10-2024 |
$7.15 | $7.14 | $7.15 | $7.5393 | $7.06 | 817,324 | 06-07-2024 |
$7.28 | $6.78 | $7.28 | $7.6935 | $6.7212 | 2,142,505 | 06-06-2024 |
$6.87 | $6 | $6.87 | $7.2299 | $6 | 2,833,661 | 06-05-2024 |
$5.88 | $6.1 | $5.88 | $6.1 | $5.72 | 1,330,907 | 06-04-2024 |
$6.01 | $6.15 | $6.01 | $6.3714 | $5.87 | 780,856 | 06-03-2024 |
$6.01 | $7.1 | $6.01 | $7.1 | $5.715 | 2,099,119 | 05-31-2024 |
$7.02 | $6.8 | $7.02 | $7.06 | $6.66 | 657,687 | 05-30-2024 |
$6.75 | $6.19 | $6.75 | $6.8 | $6.08 | 1,158,553 | 05-29-2024 |
$6.32 | $6.09 | $6.32 | $6.44 | $5.98 | 804,656 | 05-28-2024 |
$6 | $5.9 | $6 | $6.05 | $5.8 | 440,985 | 05-27-2024 |
$6 | $5.9 | $6 | $6.05 | $5.8 | 440,985 | 05-24-2024 |
$5.86 | $5.93 | $5.86 | $6.14 | $5.64 | 684,036 | 05-23-2024 |
$5.93 | $6.1 | $5.93 | $6.25 | $5.89 | 365,578 | 05-22-2024 |
$6.12 | $6.27 | $6.12 | $6.359 | $5.98 | 870,505 | 05-21-2024 |
$6.25 | $5.92 | $6.25 | $6.28 | $5.75 | 630,103 | 05-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Inc. Company Name:
TERN Stock Symbol:
NASDAQ Market:
FOSTER CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bio...
FOSTER CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product candidates to address serious diseases, including on...
FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage bio...